Related Experiment Video
Updated: Jun 16, 2026

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
Pharmacological modulation of genome and proteome alterations in mice treated with the endocrine disruptor bisphenol
Alberto Izzotti1, Mariagrazia Longobardi, Cristina Cartiglia
1Department of Health Sciences, University of Genoa, Via A. Pastore 1, I-16132 Genoa, Italy.
Abstract:
Among endocrine disruptors, the xenoestrogen bisphenol A (BPA) is of particular interest due to the very high production and widespread environmental contamination. We recently demonstrated that the oral administration of BPA to mice results in the formation of DNA adducts not only in liver but also in mammary tissue. The present study aimed at evaluating the modulation of BPA-related DNA adducts and proteome alterations by the chemopreventive agents budesonide (BUD) and phenethyl isothiocyanate (PEITC). Swiss ICR (CD-1) mice received, for 8 days, BPA with the drinking water and either chemopreventive agent with the diet. We measured DNA adducts by (32)P postlabeling and 656 proteins by antibody microarray. BPA induced the formation, with similar patterns, of DNA adducts in liver and in mammary tissue. Moreover, BPA dysregulated 13 proteins in mammary tissue, mostly in the sense of upregulation, including estrogen receptor-beta and proteins involved in cell proliferation, inhibition of apoptosis, tissue remodeling, inflammation, stress response, and glutathione synthesis. PEITC significantly inhibited the formation of BPA-induced DNA adducts, but only at the highest dose tested, and BUD was totally ineffective. The chemopreventive agents modulated a variety of BPA-induced changes in proteome profiles. However, as shown by both hierarchical cluster analysis and principal component analysis, BUD and especially PEITC were not able to restore the physiological situation in BPA-treated mice. Therefore, the in vivo use of proteome analysis proves to be a sensitive tool for the early prediction not only of protective effects but also of adverse effects of chemopreventive agents.
Insights
The chemopreventive agent phenethyl isothiocyanate (PEITC) partially reduced bisphenol A (BPA)-induced DNA damage in mice, while budesonide (BUD) was ineffective. Proteome analysis revealed BPA altered key cellular processes, and neither agent fully restored normal function.
Area of Science:
- Endocrinology
- Toxicology
- Molecular Biology
Background:
- Bisphenol A (BPA) is a widespread environmental endocrine disruptor with known genotoxicity.
- Previous studies showed BPA induces DNA adducts in mouse liver and mammary tissue.
- Chemopreventive agents are explored for mitigating BPA's adverse effects.
Purpose of the Study:
- To evaluate the efficacy of budesonide (BUD) and phenethyl isothiocyanate (PEITC) in modulating BPA-induced DNA adducts and proteome alterations.
- To assess the potential of proteome analysis for predicting chemopreventive agent efficacy and adverse effects.
Main Methods:
- Swiss ICR (CD-1) mice were administered BPA orally and either BUD or PEITC via diet for 8 days.
- DNA adducts were quantified using (32)P postlabeling.
- Proteome alterations were analyzed using antibody microarrays targeting 656 proteins.
Main Results:
- BPA induced similar DNA adduct formation in liver and mammary tissues.
- BPA dysregulated 13 proteins in mammary tissue, including estrogen receptor-beta, affecting cell proliferation, apoptosis, and stress response.
- PEITC significantly inhibited BPA-induced DNA adducts at the highest dose; BUD showed no effect.
- Both agents modulated BPA-induced proteome changes, but neither fully restored physiological conditions.
Conclusions:
- PEITC demonstrated partial chemopreventive activity against BPA-induced genotoxicity.
- Proteome analysis is a sensitive tool for evaluating both the protective and adverse effects of chemopreventive agents in vivo.
- Neither BUD nor PEITC fully reversed BPA-induced molecular disruptions in the tested model.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Microbiota Modulation by Antibiotics
Pharmacogenomics: Identification of New Drug Targets
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation

